Ming Jin

1.5k total citations
64 papers, 1.2k citations indexed

About

Ming Jin is a scholar working on Plant Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming Jin has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Plant Science, 12 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming Jin's work include Sunflower and Safflower Cultivation (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Ming Jin is often cited by papers focused on Sunflower and Safflower Cultivation (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Pulmonary Hypertension Research and Treatments (4 papers). Ming Jin collaborates with scholars based in China, United States and United Kingdom. Ming Jin's co-authors include Baoxia Zang, Adil I. Khan, Lin Wang, Yan Wu, Chunyan Sun, Ruiyan Pan, Tan Li, Yadan Zhang, Yan Zhang and Yoichiro Ito and has published in prestigious journals such as Nature Communications, Journal of Cleaner Production and Scientific Reports.

In The Last Decade

Ming Jin

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Jin China 20 389 388 153 142 139 64 1.2k
Laura Pucci Italy 28 502 1.3× 297 0.8× 131 0.9× 180 1.3× 135 1.0× 91 2.3k
Lan Su China 32 452 1.2× 337 0.9× 96 0.6× 134 0.9× 67 0.5× 69 4.5k
In‐Chul Lee South Korea 21 465 1.2× 135 0.3× 168 1.1× 91 0.6× 173 1.2× 81 1.3k
Jung‐Jin Lee South Korea 25 852 2.2× 174 0.4× 99 0.6× 166 1.2× 105 0.8× 67 1.7k
Dina S. El‐Agamy Egypt 23 470 1.2× 205 0.5× 101 0.7× 164 1.2× 135 1.0× 60 1.5k
Salman Ahmed Pakistan 18 599 1.5× 223 0.6× 290 1.9× 76 0.5× 81 0.6× 116 1.6k
Siying Li China 27 901 2.3× 283 0.7× 137 0.9× 203 1.4× 239 1.7× 119 2.0k
Somdet Srichairatanakool Thailand 25 404 1.0× 201 0.5× 135 0.9× 98 0.7× 38 0.3× 129 2.0k
Liya Liu China 28 921 2.4× 301 0.8× 155 1.0× 130 0.9× 124 0.9× 137 2.2k
J. Cruz Canada 8 415 1.1× 133 0.3× 112 0.7× 107 0.8× 139 1.0× 10 1.8k

Countries citing papers authored by Ming Jin

Since Specialization
Citations

This map shows the geographic impact of Ming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Jin more than expected).

Fields of papers citing papers by Ming Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Jin. The network helps show where Ming Jin may publish in the future.

Co-authorship network of co-authors of Ming Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Jin. A scholar is included among the top collaborators of Ming Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Jin. Ming Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qinghua, Xiaohong Luo, Peng Jin, et al.. (2025). Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption. Nature Communications. 16(1). 6100–6100. 1 indexed citations
2.
Jin, Peng, Muhammad Irfan, Yiming Qi, et al.. (2025). Chitosan as oral absorption enhancer and inhibitor: A comprehensive review. Chinese Chemical Letters. 37(1). 111273–111273. 1 indexed citations
3.
Wu, Hao, Ming Jin, Shuangqing Wang, et al.. (2024). A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation. International Journal of Pharmaceutics. 664. 124625–124625. 3 indexed citations
4.
Qi, Yiming, Ming Jin, Qing Li, et al.. (2023). Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs. Journal of Controlled Release. 360. 831–841. 13 indexed citations
5.
Wu, Qinghua, Qing Li, Ming Jin, et al.. (2022). Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy. Advanced Science. 9(21). e2200999–e2200999. 16 indexed citations
6.
Shah, Archana, et al.. (2020). Hepatitis Testing Performance of an Analyzer Integrated into Another Manufacturer’s Automation System. The Journal of Applied Laboratory Medicine. 5(4). 716–723.
7.
Meng, Zheng, Xinjing Guo, Ruiyan Pan, et al.. (2019). Hydroxysafflor Yellow A Alleviates Ovalbumin-Induced Asthma in a Guinea Pig Model by Attenuateing the Expression of Inflammatory Cytokines and Signal Transduction. Frontiers in Pharmacology. 10. 328–328. 26 indexed citations
8.
Jin, Ming, Yu Wang, Fang Dong, et al.. (2018). Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats. Chinese Journal of Integrative Medicine. 25(10). 750–756. 11 indexed citations
9.
Jin, Ming, Lin Wang, Yan Wu, Baoxia Zang, & Tan Li. (2018). Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats. Chinese Journal of Integrative Medicine. 24(1). 32–39. 22 indexed citations
10.
Pan, Ruiyan, Yadan Zhang, Zheng Meng, Baoxia Zang, & Ming Jin. (2017). Hydroxysafflor Yellow A Suppresses MRC-5 Cell Activation Induced by TGF-β1 by Blocking TGF-β1 Binding to TβRII. Frontiers in Pharmacology. 8. 264–264. 29 indexed citations
11.
Gao, Wanzhen, X. Grace, Yin Tan, et al.. (2014). Culturally Appropriate Education Intervention on Biospecimen Research Participation among Chinese Americans. Cancer Epidemiology Biomarkers & Prevention. 23(3). 383–391. 16 indexed citations
12.
Gao, Wanzhen, X. Grace, Yin Tan, et al.. (2014). Factors Associated with Willingness to Participate in Biospecimen Research Among Chinese Americans. Biopreservation and Biobanking. 12(2). 131–138. 21 indexed citations
13.
Jin, Ming. (2010). Mitigation of safflor yellow injection on acute lung injury of rats induced by oleic acid. Zhongcaoyao. 4 indexed citations
14.
Jin, Ming. (2006). Inhibitory Effect of Hydroxysafflor Yellow A Against Rat Myocardial Mitochondrial Injury. Zhōnghuá yàoxué zázhì. 4 indexed citations
15.
Jin, Ming. (2005). Determination of atropine in plasma and urine by HPLC. Chinese Journal of Hospital Pharmacy. 1 indexed citations
16.
Jin, Ming. (2004). Preparation of safflor yellow and hydroxysafflor yellow A by macroporous resin column chromatography. Zhongcaoyao. 2 indexed citations
17.
Chen, Yu, et al.. (2003). Effects of Rhubarb Compound of on Adipocyte Leptin and C/ EBP #alpha# Expression in Obese Rats. Zhongguo zhongyi jichu yixue zazhi. 9(4). 27–31.
18.
Jin, Ming, et al.. (2003). Development of a large-scale HPLC-based purification for the urease from Staphylococcus leei and determination of subunit structure. Protein Expression and Purification. 34(1). 111–117. 18 indexed citations
19.
Jin, Ming, et al.. (2001). Anti-tumor effect and anti-inflammatory activity ofBoschniakia rossica. Chinese Journal of Integrative Medicine. 7(3). 1 indexed citations
20.
Chen, Yingsi, et al.. (2000). Purification and Characterization of Human α-Galactosidase A Expressed in Insect Cells Using a Baculovirus Vector. Protein Expression and Purification. 20(2). 228–236. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026